Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01090206 |
Recruitment Status
:
Completed
First Posted
: March 19, 2010
Last Update Posted
: April 29, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Hemophilia A Hemophilia B Vitamin D Deficiency | Dietary Supplement: Vitamin D and calcium | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia |
Study Start Date : | March 2010 |
Actual Primary Completion Date : | March 2013 |
Actual Study Completion Date : | March 2015 |

Arm | Intervention/treatment |
---|---|
Hemophilia, Vitamin D deficiency
|
Dietary Supplement: Vitamin D and calcium
Doses will be based on Vitamin D levels
|
- Correlate between Vitamin D deficiency, low bone mass and lack of weight bearing physical activity [ Time Frame: 1year ]
- Determine bone mass (density) in hemophilia patients [ Time Frame: 1 yr ]
- establish dose and duration of treatment with vitamin D [ Time Frame: 1 yr ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 2 Years to 21 Years (Child, Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- clinical diagnosis of Hemophilia A or B
- ages 2-21 years
Exclusion Criteria:
- therapeutic vitamin D or calcium supplementation within 3 months of study entry

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01090206
United States, Virginia | |
Virginia Commonwealth University Health System | |
Richmond, Virginia, United States, 23298 |
Principal Investigator: | Gita V Massey, M.D. | Virginia Commonwealth University |
Responsible Party: | Virginia Commonwealth University |
ClinicalTrials.gov Identifier: | NCT01090206 History of Changes |
Other Study ID Numbers: |
PT 104212 |
First Posted: | March 19, 2010 Key Record Dates |
Last Update Posted: | April 29, 2016 |
Last Verified: | April 2016 |
Keywords provided by Virginia Commonwealth University:
Hemophilia Vitamin D |
Additional relevant MeSH terms:
Hemophilia A Hemophilia B Vitamin D Deficiency Blood Coagulation Disorders, Inherited Blood Coagulation Disorders Hematologic Diseases Coagulation Protein Disorders Hemorrhagic Disorders Genetic Diseases, Inborn Avitaminosis Deficiency Diseases |
Malnutrition Nutrition Disorders Genetic Diseases, X-Linked Vitamins Vitamin D Ergocalciferols Micronutrients Growth Substances Physiological Effects of Drugs Bone Density Conservation Agents |